Nano Therapies, Mega Results

Our Company

Nami Therapeutics Corp (’Nami’) is a startup company based in Storrs, CT and currently in the Technology Incubation Program at the University of Connecticut. Nami is developing specifically designed nanoparticles for the targeted delivery of therapeutic agents, including radio-therapeutics, to tumors. Nami (which mean ‘nano’ in Mandarin) is using technologies licensed from the University of Connecticut and the University of North Carolina. The Nami team is comprised of Xiuling Lu and Michael Jay, academics with over 50 years of collective experience in the drug delivery field, Ruobing Xia, who has 20+ years of experience in big pharma managing multi-million dollar product launches, and David Worthen, an experienced scientist and entrepreneur with product development, regulatory affairs, and management experience in both industry and academia. View More  

We welcome passionate individuals and specialty professionals to join our team.